The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: Report from the Stockholm Cohort of Atrial Fibrillation (SCAF)

Heart

Volumn 95, Issue 12, 2009, Pages 1000-1005

  Friberg, L ^a,e   Hammar, N ^b,c   Edvardsson, N ^d   Rosenqvist, M ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e GlobenHeart Clinic   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIRECT CURRENT; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RELAPSE; SINUS RHYTHM;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DISEASE PROGRESSION; ELECTRIC COUNTERSHOCK; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 67649344814     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.149237     Document Type: Article

References (14)

1. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New Engl J Med 2002;347:1834-1840 (Pubitemid 35417774)
2. Hagens VE, Crijns HJ, Van Veldhuisen DJ, et al. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J 2005;149:1106-1111 (Pubitemid 40848157)
3. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. New Engl J Med 2002;347:1825-1833 (Pubitemid 35417773)
4. Curtis AB, Gersh BJ, Corley SD, et al. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:645-649 (Pubitemid 40501489)
5. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-1513 (Pubitemid 38420179)
6. Pedersen OD, Brendorp B, Elming H, et al. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study. Card Electrophysiol Rev 2003;7:220-224 (Pubitemid 38256102)
7. Friberg L, Hammar N, Ringh M, et al. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J 2006;27:1954-1964. (Pubitemid 44297370)
8. Friberg L, Hammar N, Pettersson H, et al. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J 2007;28:2346-2353 (Pubitemid 47537782)
9. Rienstra M, Van Gelder IC, Hagens VE, et al. Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study. Eur Heart J 2006;27:357-364 (Pubitemid 43100033)
10. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745. (Pubitemid 44472247)
11. Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131:927-934 (Pubitemid 30005032)
12. Frykman V, Beerman B, Ryden L, et al. Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J 2001;22:1954-1959 (Pubitemid 33054676)
13. Boriani G, Diemberger I, Biffi M, et al. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract 2007;61:748-756 (Pubitemid 46587866)
14. Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-46